priority review

Do Drugs Approved Via Expedited Pathways Offer Greater Benefits? Study and Doctors Debate
Do Drugs Approved Via Expedited Pathways Offer Greater Benefits? Study and Doctors Debate
RAPS.org
drug approvals
FDA
priority review
accelerated approvals
fast track
breakthrough status
Flag link:
GSK uses priority voucher to file HIV combo
GSK uses priority voucher to file HIV combo
BioPharma Dive
GSK
priority review
HIV
ViiV
Flag link:
Bayer cancer drug boards path to speedy approval at FDA
Bayer cancer drug boards path to speedy approval at FDA
Fierce Biotech
Bayer
FDA
copanlisib
priority review
non-Hodgkin's lymphoma
Flag link:
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
Yahoo
Amgen
FDA
priority review
Blincyto
acute lymphoblastic leukemia
Flag link:
Sarepta Sells Priority Review Voucher for $125M
Sarepta Sells Priority Review Voucher for $125M
Investopedia
Sarepta Therapeutics
Gilead Sciences
priority review
FDA
Flag link:
Pfizer shortens comeback campaign for armed antibody inotuzumab, lands quick FDA review
Pfizer shortens comeback campaign for armed antibody inotuzumab, lands quick FDA review
Endpoints
Pfizer
inotuzumab ozogamicin
B cell acute lymphoblastic leukemia
priority review
FDA
Flag link:
Merck shares rise after hours on priority review lung cancer drug application
Merck shares rise after hours on priority review lung cancer drug application
Marketwatch
Merck
Keytruda
lung cancer
priority review
FDA
Flag link:
The FDA in 2016: By the numbers
The FDA in 2016: By the numbers
Medical Marketing and Media
FDA
drug approvals
priority review
breakthrough status
Flag link:
FDA Grants Merck Priority Review for Keytruda Drug (MRK)
FDA Grants Merck Priority Review for Keytruda Drug (MRK)
Investopedia
FDA
priority review
Keytruda
Merck
non-small cell lung cancer
anti-PD-L1
Flag link:
FDA accepts Merck & Co.'s Keytruda filing for first-line treatment of NSCLC, grants priority review
FDA accepts Merck & Co.'s Keytruda filing for first-line treatment of NSCLC, grants priority review
First Word Pharma
Merck
FDA
Keytruda
non-small cell lung cancer
priority review
Flag link:
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Bloomberg
Clovis Oncology
FDA
priority review
rucaparib
ovarian cancer
Flag link:
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Fierce Pharma
Eisai
Lenvima
kidney cancer
FDA
priority review
Flag link:
Gilead gets FDA priority review of Hepatitis C combo drug
Gilead gets FDA priority review of Hepatitis C combo drug
Marketwatch
Gilead Sciences
FDA
priority review
hepatitis C
Sovaldi-velpatasir
Flag link:
Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer
Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer
Yahoo
Pfizer
FDA
Ibrance
priority review
metastatic breast cancer
Flag link:
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Fierce Pharma
Bristol-Myers Squibb
FDA
priority review
Opdivo
kidney cancer
Flag link:
The FDA is lukewarm on those hyper-valuable vouchers for fast drug reviews
The FDA is lukewarm on those hyper-valuable vouchers for fast drug reviews
Fierce Biotech
FDA
priority review
review vouchers
Flag link:
AstraZeneca nabs priority review voucher as Wellstat bags FDA OK
AstraZeneca nabs priority review voucher as Wellstat bags FDA OK
Fierce Biotech
AstraZeneca
FDA
Wellstat
priority review
review vouchers
Xuriden
Flag link:
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Flag link:
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti
Flag link:
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
Yahoo
FDA
Intercept Pharma
obeticholic acid
priority review
primary biliary cirrhosis
Flag link: